Oklahoma 2026 Regular Session

Oklahoma Senate Bill SB883

Introduced
2/3/25  

Caption

Abortion; prohibiting certain acts involving abortion-inducing drugs; providing administrative and criminal penalties. Emergency.

Summary

SB883 would create a new section of Oklahoma law targeting abortion-inducing drugs. It defines “abortion” and “abortion-inducing drug,” expressly naming medications such as mifepristone, misoprostol, and methotrexate when used with the intent to terminate a pregnancy, while excluding drugs used for other medical purposes. The bill prohibits any person from knowingly or recklessly giving, selling, dispensing, administering, prescribing, distributing, trafficking, or otherwise providing such drugs in Oklahoma when they are intended to induce an abortion in violation of existing law or to induce labor with the intent to cause the death of the unborn person after live birth through intentional or negligent acts. The bill establishes significant penalties for violations. A person convicted under the measure would be guilty of a felony, and any health care provider found in violation would have their professional license immediately revoked by the relevant licensing board. SB883 also includes an inseverability clause, meaning if any part of the act is struck down, the entire act would become invalid. In addition, it repeals a long list of existing Oklahoma statutes related to abortion-inducing drugs and declares an emergency so the act would take effect immediately upon passage and approval. The bill’s impact would be to substantially tighten Oklahoma’s regulation of medication abortion and related drug distribution, while also eliminating prior statutory provisions in Title 63 that address abortion-inducing drugs. It would expand criminal exposure for providers and others involved in the supply chain and impose mandatory professional discipline on licensed health care providers. Because it is written as an emergency measure, it is intended to take effect without the usual delay. The available context shows no recorded committee debate or vote history, so there is no documented legislative discussion to gauge support or opposition. Based on the bill’s subject matter and structure, it appears to be a strongly anti-abortion measure designed to restrict medication abortion and deter providers through felony penalties and license revocation. The absence of transcripts means specific points of contention are not documented, but likely areas of dispute would include the scope of the drug ban, the inclusion of off-label use, and the severity of the penalties.

Impact

SB883 would add a new prohibition in Title 63 against providing abortion-inducing drugs for prohibited abortion purposes, while also repealing multiple existing Oklahoma statutes on abortion-inducing drugs. It would create felony liability for violators and require immediate revocation of a health care provider’s license upon conviction, thereby affecting physicians, pharmacists, clinics, and others involved in medication abortion. The bill also includes an emergency clause and an inseverability provision, increasing its immediate and comprehensive legal effect.

Sentiment

No committee transcripts or votes were provided, so there is no direct record of debate, amendments, or roll-call support/opposition. The bill’s text and caption indicate a clear policy direction toward restricting abortion-inducing drugs, suggesting support from anti-abortion lawmakers and likely opposition from abortion-rights advocates and some medical stakeholders. Overall, the measure appears to be framed as a high-priority public policy and public safety bill by its sponsors, as reflected in the emergency clause.

Contention

The main likely points of contention are the bill’s broad prohibition on abortion-inducing drugs, the inclusion of commonly used medications such as mifepristone and misoprostol when used for abortion, and the severe penalties attached to violations. Health care providers and reproductive-rights advocates would likely object to the felony penalty, mandatory license revocation, and the bill’s reach into medication abortion and off-label drug use. Supporters would likely argue it is necessary to enforce existing abortion restrictions and prevent unlawful abortions, but no formal debate record is available in the provided materials.

Companion Bills

OK SB883

Carry Over Abortion; prohibiting certain acts involving abortion-inducing drugs; providing administrative and criminal penalties. Emergency.

Previously Filed As

OK SB883

Abortion; prohibiting certain acts involving abortion-inducing drugs; providing administrative and criminal penalties. Emergency.

OK HB1169

Abortion-inducing drugs; repealer; emergency.

OK SB989

Abortion; creating the Wrongful Death Protection Act of 2025; making certain individuals liable for wrongful death from abortion-inducing drugs. Emergency.

OK HB1168

Abortion-inducing drugs; terms; trafficking; felony; exceptions; effective date.

OK SB884

Abortion; creating the Oklahoma Right to Life Act; prohibiting certain acts; imposing certain duty on health care providers; providing certain penalty and immunities. Emergency.

OK SB456

Abortion; creating the Abolition of Abortion Act; modifying applicability of provisions related to homicide and wrongful death. Emergency.

OK HB1008

Abortion; prohibition of abortion; definitions; prescribing standard based upon preservation of the life of a pregnant woman; emergency.

OK SB1002

Gender transition procedures; prohibiting certain use of public funds; providing penalties. Effective date. Emergency.

OK HB1724

Abortion pills; Prevention of Maternal Harm Act of 2025; coerced abortion; imprisonment; fines; Schedule IV; mifepristone and misoprostol; effective date.

OK SB791

Banks and trusts companies; prohibiting certain institutions from providing certain information to certain agents; establishing penalties. Effective date. Emergency.

Similar Bills

No similar bills found.